MOR logo

MorphoSys AG (MOR) EBIT

MOR Annual EBIT

-$87.76 M
-$229.12 M-162.08%

31 December 2023

MOR EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MOR Quarterly EBIT

$59.38 M
+$115.99 M+204.87%

31 December 2023

MOR Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MOR TTM EBIT

-$62.41 M
-$148.34 M-172.62%

31 December 2023

MOR TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MOR EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-162.1%-71.4%-148.7%
3 y3 years-280.9%+142.0%-281.1%
5 y5 years-24.4%+142.0%-281.1%

MOR EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-157.6%-75.9%-133.3%

MorphoSys AG EBIT History

DateAnnualQuarterlyTTM
Dec 2023
-$87.76 M(-162.1%)
$59.38 M(-204.9%)
-$62.41 M(-172.6%)
Sept 2023
-
-$56.62 M(+18.5%)
$85.93 M(-54.1%)
June 2023
-
-$47.80 M(+175.2%)
$187.38 M(+5.4%)
Mar 2023
-
-$17.37 M(-108.4%)
$177.80 M(+38.9%)
Dec 2022
$141.36 M(-122.7%)
$207.72 M(+363.4%)
$128.03 M(-121.9%)
Sept 2022
-
$44.83 M(-178.1%)
-$585.24 M(-19.4%)
June 2022
-
-$57.38 M(-14.5%)
-$725.92 M(-3.8%)
Mar 2022
-
-$67.14 M(-86.7%)
-$754.55 M(+6.7%)
Dec 2021
-$621.44 M(-1381.3%)
-$505.55 M(+427.4%)
-$707.18 M(+106.1%)
Sept 2021
-
-$95.86 M(+11.5%)
-$343.13 M(+21.7%)
June 2021
-
-$86.01 M(+334.9%)
-$281.94 M(+21.4%)
Mar 2021
-
-$19.77 M(-86.0%)
-$232.17 M(-773.6%)
Dec 2020
$48.50 M(-141.1%)
-$141.50 M(+308.2%)
$34.47 M(-70.5%)
Sept 2020
-
-$34.66 M(-4.3%)
$116.72 M(-5.9%)
June 2020
-
-$36.23 M(-114.7%)
$124.04 M(-19.6%)
Mar 2020
-
$246.86 M(-516.7%)
$154.29 M(-231.1%)
Dec 2019
-$118.10 M(+67.5%)
-$59.25 M(+116.7%)
-$117.65 M(+5.5%)
Sept 2019
-
-$27.34 M(+356.8%)
-$111.52 M(+129.0%)
June 2019
-
-$5.99 M(-76.1%)
-$48.70 M(-32.4%)
Mar 2019
-
-$25.08 M(-52.8%)
-$72.08 M(+2.3%)
Dec 2018
-$70.52 M(-6.9%)
-$53.11 M(-249.7%)
-$70.45 M(+110.0%)
Sept 2018
-
$35.47 M(-220.8%)
-$33.54 M(-65.1%)
June 2018
-
-$29.36 M(+25.2%)
-$96.05 M(+15.0%)
Mar 2018
-
-$23.45 M(+44.7%)
-$83.55 M(+10.1%)
Dec 2017
-$75.76 M(+14.4%)
-$16.20 M(-40.0%)
-$75.88 M(-16.2%)
Sept 2017
-
-$27.03 M(+60.2%)
-$90.50 M(+16.6%)
June 2017
-
-$16.87 M(+6.9%)
-$77.61 M(+9.2%)
Mar 2017
-
-$15.78 M(-48.8%)
-$71.05 M(+8.1%)
Dec 2016
-$66.23 M(-389.1%)
-$30.82 M(+118.0%)
-$65.73 M(+23.6%)
Sept 2016
-
-$14.14 M(+37.1%)
-$53.18 M(+3.9%)
June 2016
-
-$10.31 M(-1.4%)
-$51.16 M(+6.1%)
Mar 2016
-
-$10.46 M(-42.8%)
-$48.25 M(-297.7%)
Dec 2015
$22.91 M
-$18.27 M(+50.8%)
$24.40 M(-39.3%)
DateAnnualQuarterlyTTM
Sept 2015
-
-$12.12 M(+63.9%)
$40.22 M(-16.4%)
June 2015
-
-$7.39 M(-111.9%)
$48.12 M(-11.8%)
Mar 2015
-
$62.19 M(-2636.0%)
$54.55 M(-1117.5%)
Dec 2014
-$5.57 M(-139.2%)
-$2.45 M(-41.9%)
-$5.36 M(-41.2%)
Sept 2014
-
-$4.22 M(+339.7%)
-$9.11 M(+8.6%)
June 2014
-
-$960.50 K(-142.2%)
-$8.39 M(-166.9%)
Mar 2014
-
$2.27 M(-136.7%)
$12.55 M(-8.5%)
Dec 2013
$14.21 M(+261.3%)
-$6.21 M(+77.2%)
$13.71 M(-46.3%)
Sept 2013
-
-$3.50 M(-117.5%)
$25.54 M(-9.8%)
June 2013
-
$19.98 M(+480.3%)
$28.32 M(+244.9%)
Mar 2013
-
$3.44 M(-38.8%)
$8.21 M(+105.8%)
Dec 2012
$3.93 M(-74.8%)
$5.62 M(-877.6%)
$3.99 M(-132.4%)
Sept 2012
-
-$723.00 K(+457.4%)
-$12.32 M(-23.6%)
June 2012
-
-$129.70 K(-83.4%)
-$16.12 M(-32.8%)
Mar 2012
-
-$779.30 K(-92.7%)
-$24.00 M(-260.4%)
Dec 2011
$15.65 M(-10.6%)
-$10.69 M(+136.4%)
$14.96 M(-49.7%)
Sept 2011
-
-$4.52 M(-43.5%)
$29.72 M(-17.8%)
June 2011
-
-$8.01 M(-121.0%)
$36.16 M(-26.9%)
Mar 2011
-
$38.18 M(+838.8%)
$49.44 M(+181.0%)
Dec 2010
$17.50 M(-3.8%)
$4.07 M(+112.4%)
$17.60 M(+4.3%)
Sept 2010
-
$1.91 M(-63.7%)
$16.87 M(-12.8%)
June 2010
-
$5.28 M(-16.6%)
$19.36 M(+9.7%)
Mar 2010
-
$6.34 M(+89.7%)
$17.64 M(-1.8%)
Dec 2009
$18.19 M(-31.1%)
$3.34 M(-24.1%)
$17.96 M(+22.8%)
Sept 2009
-
$4.40 M(+23.3%)
$14.62 M(+43.1%)
June 2009
-
$3.57 M(-46.4%)
$10.22 M(+53.6%)
Mar 2009
-
$6.65 M
$6.65 M
Dec 2008
$26.41 M(+108.7%)
-
-
Dec 2007
$12.65 M(-87.8%)
-
-
Dec 2006
$103.58 M(+135.8%)
-
-
Dec 2005
$43.94 M(+5407.8%)
-
-
Dec 2004
$797.70 K(-123.1%)
-
-
Dec 2003
-$3.46 M(-85.7%)
-
-
Dec 2002
-$24.14 M
-
-

FAQ

  • What is MorphoSys AG annual earnings before interest & taxes?
  • What is the all time high annual EBIT for MorphoSys AG?
  • What is MorphoSys AG annual EBIT year-on-year change?
  • What is MorphoSys AG quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for MorphoSys AG?
  • What is MorphoSys AG quarterly EBIT year-on-year change?
  • What is MorphoSys AG TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for MorphoSys AG?
  • What is MorphoSys AG TTM EBIT year-on-year change?

What is MorphoSys AG annual earnings before interest & taxes?

The current annual EBIT of MOR is -$87.76 M

What is the all time high annual EBIT for MorphoSys AG?

MorphoSys AG all-time high annual earnings before interest & taxes is $152.47 M

What is MorphoSys AG annual EBIT year-on-year change?

Over the past year, MOR annual earnings before interest & taxes has changed by -$229.12 M (-162.08%)

What is MorphoSys AG quarterly earnings before interest & taxes?

The current quarterly EBIT of MOR is $59.38 M

What is the all time high quarterly EBIT for MorphoSys AG?

MorphoSys AG all-time high quarterly earnings before interest & taxes is $246.86 M

What is MorphoSys AG quarterly EBIT year-on-year change?

Over the past year, MOR quarterly earnings before interest & taxes has changed by -$148.34 M (-71.41%)

What is MorphoSys AG TTM earnings before interest & taxes?

The current TTM EBIT of MOR is -$62.41 M

What is the all time high TTM EBIT for MorphoSys AG?

MorphoSys AG all-time high TTM earnings before interest & taxes is $187.38 M

What is MorphoSys AG TTM EBIT year-on-year change?

Over the past year, MOR TTM earnings before interest & taxes has changed by -$190.43 M (-148.74%)